Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (H.R. 307; 113th Congress)

Оглавление

Mike Rogers. Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (H.R. 307; 113th Congress)

Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (H.R. 307; 113th Congress)

Table of Contents

Section 1. Short title; table of contents

(a) Short title–

(b) Table of contents–

Title I—Strengthening national preparedness and response for public health emergencies. Sec. 101. National Health Security Strategy

Sec. 102. Assistant Secretary for Preparedness and Response

(E) Identification of inefficiencies–

(F) Coordination of grants and agreements–

(G) Drill and operational exercises–

(b) Interagency coordination plan–

Sec. 103. National Advisory Committee on Children and Disasters

Sec. 2811A. National Advisory Committee on Children and Disasters

Sec. 104. Modernization of the National Disaster Medical System

Sec. 105. Continuing the role of the Department of Veterans Affairs

Title II—Optimizing State and local all-hazards preparedness and response. Sec. 201. Temporary redeployment of federally funded personnel during a public health emergency

(e) Temporary redeployment of federally funded personnel during a public health emergency–

(1) Emergency redeployment of federally funded personnel–

(2) Activation of emergency redeployment– (A) Public health emergency–

(B) Contents of request–

(C) Consideration–

(D) Termination and extension– (i) Termination–

(ii) Extension authority–

(3) Notice to personnel of possibility of redeployment–

(4) Notice to Congress–

(5) Guidance–

(6) Report to Congress–

(7) Definition–

(8) Sunset–

Sec. 202. Improving State and local public health security

(a) Cooperative agreements–

Sec. 203. Hospital preparedness and medical surge capacity

(1) In general–

(2) Meeting goals of National Health Security Strategy–

(1) In general–

Sec. 204. Enhancing situational awareness and biosurveillance

Sec. 205. Eliminating duplicative Project Bioshield reports

Title III—Enhancing Medical Countermeasure Review. Sec. 301. Special protocol assessment

Sec. 302. Authorization for medical products for use in emergencies

(m) Categorization of laboratory tests associated with devices subject to authorization– (1) In general–

(2) Conditions of determination–

(3) Effective period–

Sec. 564A. Emergency use of medical products

(b) Expiration dating– (1) In general–

(2) Requirements and conditions–

(3) Effect–

(d) Emergency dispensing–

Sec. 564B. Products held for emergency use

Sec. 303. Definitions

Sec. 304. Enhancing medical countermeasure activities

(c) Final Guidance on development of animal models– (1) In general–

(2) Authority to extend deadline–

Sec. 305. Regulatory management plans

(A) Plans for security countermeasures–

(B) Plans for other eligible countermeasures–

Sec. 306. Report

Sec. 307. Pediatric medical countermeasures

Title IV—Accelerating medical countermeasure advanced research and development. Sec. 401. BioShield

(b) Reauthorization of the special reserve fund–

(g) Special reserve fund– (1) Authorization of appropriations–

(2) Use of special reserve fund for advanced research and development–

(3) Restrictions on use of funds–

(h) Definitions–

Sec. 402. Biomedical Advanced Research and Development Authority

(1) In general–

(2) Effective date–

Sec. 403. Strategic National Stockpile

Sec. 404. National Biodefense Science Board